Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Total Liabilities (2018 - 2025)

Historic Total Liabilities for Neurogene (NGNE) over the last 6 years, with Q3 2025 value amounting to $22.3 million.

  • Neurogene's Total Liabilities fell 1652.81% to $22.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.3 million, marking a year-over-year decrease of 1652.81%. This contributed to the annual value of $25.4 million for FY2024, which is 3062.74% down from last year.
  • Latest data reveals that Neurogene reported Total Liabilities of $22.3 million as of Q3 2025, which was down 1652.81% from $24.1 million recorded in Q2 2025.
  • In the past 5 years, Neurogene's Total Liabilities ranged from a high of $36.5 million in Q4 2023 and a low of $14.4 million during Q3 2023
  • For the 3-year period, Neurogene's Total Liabilities averaged around $23.1 million, with its median value being $24.1 million (2025).
  • Examining YoY changes over the last 5 years, Neurogene's Total Liabilities showed a top increase of 8609.16% in 2024 and a maximum decrease of 3062.74% in 2024.
  • Neurogene's Total Liabilities (Quarter) stood at $36.5 million in 2023, then crashed by 30.63% to $25.4 million in 2024, then dropped by 12.08% to $22.3 million in 2025.
  • Its Total Liabilities stands at $22.3 million for Q3 2025, versus $24.1 million for Q2 2025 and $23.5 million for Q1 2025.